Related references
Note: Only part of the references are listed.Assessment of false-negative cases of breast MR imaging in women with a familial or genetic predisposition
Inge-Marie A. Obdeijn et al.
BREAST CANCER RESEARCH AND TREATMENT (2010)
Pathologic Complete Response Rates in Young Women With BRCA1-Positive Breast Cancers After Neoadjuvant Chemotherapy
Tomasz Byrski et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Early Diagnosis of Hereditary Breast Cancer by Magnetic Resonance Imaging: What Is Realistic?
Jan G. M. Klijn
JOURNAL OF CLINICAL ONCOLOGY (2010)
Prospective Multicenter Cohort Study to Refine Management Recommendations for Women at Elevated Familial Risk of Breast Cancer: The EVA Trial
Christiane Kuhl et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Sensitivity to First-Line Chemotherapy for Metastatic Breast Cancer in BRCA1 and BRCA2 Mutation Carriers
Mieke Kriege et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Multimodality Screening of High-Risk Women: A Prospective Cohort Study
Susan P. Weinstein et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Meta-analysis of Risk Reduction Estimates Associated With Risk-Reducing Salpingo-oophorectomy in BRCA1 or BRCA2 Mutation Carriers
Timothy R. Rebbeck et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2009)
Breast cancer screening in women at high risk using MRI
Martin O. Leach
NMR IN BIOMEDICINE (2009)
Cancers in BRCA1 and BRCA2 Carriers and in Women at High Risk for Breast Cancer: MR Imaging and Mammographic Features
Fiona J. Gilbert et al.
RADIOLOGY (2009)
Systematic review: Using magnetic resonance imaging to screen women at high risk for breast cancer
Ellen Warner et al.
ANNALS OF INTERNAL MEDICINE (2008)
International variation in rates of uptake of preventive options in BRCA1 and BRCA2 mutation carriers
Kelly A. Metcalfe et al.
INTERNATIONAL JOURNAL OF CANCER (2008)
BRCA1 mutation and young age predict fast breast cancer growth in the Dutch, United Kingdom, and Canadian magnetic resonance imaging screening trials
Madeleine M. A. Tilanus-Linthorst et al.
CLINICAL CANCER RESEARCH (2007)
Surveillance for familial breast cancer:: Differences in outcome according to BRCA mutation status
Pal Moller et al.
INTERNATIONAL JOURNAL OF CANCER (2007)
MRI for diagnosis of pure ductal carcinoma in situ: a prospective observational study
Christiane K. Kuhl et al.
LANCET (2007)
Sensitivity of MRI versus conventional screening in the diagnosis of BRCA-associated breast cancer in a national prospective series
Anne I. Hagen et al.
BREAST (2007)
Management of an inherited predisposition to breast cancer
Mark Robson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
The cost-utility of magnetic resonance imaging for breast cancer in BRCA1 mutation carriers aged 30-49
Richard P. A. Norman et al.
EUROPEAN JOURNAL OF HEALTH ECONOMICS (2007)
American Cancer Society guidelines for breast screening with MRI as an adjunct to mammography
Debbie Saslow et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2007)
Tumour characteristics, survival and prognostic factors of hereditary breast cancer from BRCA2-, BRCA1- and non-BRCA1/2 families as compared to sporadic breast cancer cases
C. T. M. Brekelmans et al.
EUROPEAN JOURNAL OF CANCER (2007)
Prognosis of early-onset breast cancer based on BRCA1/2 mutation status in a French population-based cohort and review
Valerie Bonadona et al.
BREAST CANCER RESEARCH AND TREATMENT (2007)
Breast MR imaging in women at high-risk of breast cancer. Is something changing in early breast cancer detection?
Francesco Sardanelli et al.
EUROPEAN RADIOLOGY (2007)
The correlation of mammographic-and histologic patterns of breast cancers in BRCA1 gene mutation carriers, compared to age-matched sporadic controls
R. Kaas et al.
EUROPEAN RADIOLOGY (2006)
Cost-effectiveness of screening with contrast enhanced magnetic resonance imaging vs X-ray mammography of women at a high familial risk of breast cancer
I. Griebsch et al.
BRITISH JOURNAL OF CANCER (2006)
Cost-effectiveness of screening BRCA1/2 mutation carriers with breast magnetic resonance imaging
Sylvia K. Plevritis et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2006)
Survival and prognostic factors in BRCA1-associated breast cancer
CTM Brekelmans et al.
ANNALS OF ONCOLOGY (2006)
Mammography, breast ultrasound, and magnetic resonance imaging for surveillance of women at high familial risk for breast cancer
CK Kuhl et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Prediction of BRCA1 status in patients with breast cancer using estrogen receptor and basal phenotype
SR Lakhani et al.
CLINICAL CANCER RESEARCH (2005)
Hereditary breast cancer growth rates and its impact on screening policy
MMA Tilanus-Linthorst et al.
EUROPEAN JOURNAL OF CANCER (2005)
Screening with magnetic resonance imaging and mammography of a UK population at high familial risk of breast cancer: a prospective multicentre cohort study (MARIBS)
MO Leach et al.
LANCET (2005)
Surveillance of BRCA1 and BRCA2 mutation carriers with magnetic resonance imaging, ultrasound, mammography, and clinical breast examination
E Warner et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2004)
Efficacy of MRI and mammography for breast-cancer screening in women with a familial or genetic predisposition
M Kriege et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2
MC King et al.
SCIENCE (2003)
Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history:: A combined analysis of 22 studies
A Antoniou et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2003)
Initiation of population-based mammography screening in Dutch municipalities and effect on breast-cancer mortality: a systematic review
SJ Otto et al.
LANCET (2003)
Overview of the main outcomes in breast-cancer prevention trials
J Cuzick et al.
LANCET (2003)
A BRCA1/2 mutation, high breast density and prominent pushing margins of a tumor independently contribute to a frequent false-negative mammography
M Tilanus-Linthorst et al.
INTERNATIONAL JOURNAL OF CANCER (2002)
Breast imaging reporting and data system (BI-RADS)
L Liberman et al.
RADIOLOGIC CLINICS OF NORTH AMERICA (2002)
Breast cancer after prophylactic bilateral mastectomy in women with a BRCA1 or BRCA2 mutation.
H Meijers-Heijboer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)